Smith+Nephew announces Ambulatory Surgery Center strategy ‘Positive Connections’

Combination of consultancy, training, robotics and newly-acquired patient optimization technologies to benefit patients and healthcare providers

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces ‘Positive Connections’, a turnkey service to support healthcare providers seeking to offer increased access for orthopaedic cases to Ambulatory Surgery Centers (ASCs) and other outpatient settings.

Recent developments in surgical technology, anesthesia protocols and changes to Medicare reimbursement are triggering an upsurge in demand from providers to deliver orthopaedic procedures in outpatient settings, such as ASCs.

In such settings, suitable patients are admitted, operated on and discharged on the same day, and receive the majority of their post-acute care at home. The model brings advantages to both the patient and healthcare provider, including the patient recovering in the comfort of their home, the surgeon having greater control over the surgical setting and pre and post-acute care, and, for both parties, lower overhead costs.^1,2 With the gradual growth of ASCs in the US, those facilities now rival the number of hospitals currently operating across the country.³  

According to a recently released study by Bain & Company, the share of hip and knee replacements performed in ASCs will grow from 9 to 25 percent and 10 to 30 percent respectively by the mid-2020s. The same report indicated the shift of case volume to ASCs is already saving the US healthcare system an estimated $40 billion annually.⁴

Smith+Nephew’s Positive Connections offering will include a team of regional concierge business directors who support customers seeking to create an outpatient surgery program or improve their existing offering.

It will also offer team training for healthcare providers wanting to learn how to manage same-day total joint replacement surgery for maximum efficiency and patient satisfaction. This includes guiding physician-owners of ASCs how to build their team including administrators, anesthesiologists and operating room staff.

Positive Connections customers will be able to utilize a cloud-based application that assists surgeons with patient selection and optimization for the ASC setting and provides care management pathways, patient education and engagement assets, and outcomes reporting tools.

This application is based upon two newly completed technology acquisitions:

• MiJourney, a patient management software company based in Pittsburgh, US, that enables coordination across the entire episode of care by administrators, physicians, and patients.
• The asset purchase of a proprietary outpatient selection algorithm and ASC total joint replacement care pathway from Rapid Recovery Pathways, LLC.

“After listening to surgeons across the country, it is evident that there is an increased demand for suitable orthopaedic procedures to be performed in surgery centers and hospital outpatient departments,” said Skip Kiil, President, Global Orthopaedics at Smith+Nephew. “We’ve created a program in Positive Connections that will support this demand by combining emerging technologies and value-driven solutions with a differentiated product portfolio.”

Smith+Nephew is uniquely well-positioned to assist healthcare providers to make the transition to offering outpatient orthopaedic surgery, and is an established leader in the ASC space through its Sports Medicine franchise.

Moreover, Smith+Nephew is a leader in orthopaedic implants and enabling technologies designed to streamline and improve the clinical process. These include its robotics-assisted NAVIO Surgical System, which is low-footprint, portable and CT-free - features desired by most ASCs.

Healthcare providers wishing to learn more about Positive Connections or register for Outpatient Total Joint Experience team training may visit https://www.smith-nephew.com/positive-connections/ or view the Positive Connections video. The commercial terms of these acquisitions have not been disclosed.

 

Enquiries

 

Investors  

Andrew Swift                                                         +44 (0) 1923 477433

Smith+Nephew     

 

Media        

Dave Snyder                                                          +1 (978) 749-1440

Francesca Dunning                                                 +44 (0) 1923 477300

Smith+Nephew     

 

About Smith+Nephew

Smith+Nephew is a portfolio medical technology business that exists to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 17,500+ employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Advanced Wound Management and Sports Medicine & ENT.

Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $5.1 billion in 2019. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms ‘Group’ and ‘Smith+Nephew’ are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.

For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on Twitter, LinkedIn, Instagram or Facebook.

^{Forward-looking Statements}

^{This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations.}

^{◊ Trademark of Smith+Nephew. Certain marks registered US Patent and Trademark Office.}